AGC Biologics Celebrates U.S. and EU Approval of Fondazione Telethon’s Waskyra™ Treatment for Wiskott-Aldrich Syndrome
AGC INC UNSP/ADR (ASGLY)
NASDAQ:AMEX Investor Relations:
newsquantified.com/asgly/sec-filings-report/agc-american-depositary-receipts-unsponsored-form-f6-incadr-filed-bank-05ks9e
Company Research
Source: Business Wire
This further establishes the global leadership of AGC Biologics' Milan Cell and Gene Center of Excellence in number of commercial products approved MILAN--(BUSINESS WIRE)--With the decision by the U.S. Food and Drug Administration and the European Commission to grant market authorization for Waskyra™, a gene therapy to treat Wiskott-Aldrich syndrome, AGC Biologics’ Milan Cell and Gene Center of Excellence announced it will continue to support the commercial development of this vital, life-changing therapy for young patients worldwide.Wiskott-Aldrich syndrome is a rare immune disorder affecting approximately 1 in 250,000 live male births, leading to severe infections, increased bruising and bleeding, and other complications starting in early childhood due to problems with platelet production. Current treatment options include supportive therapies aimed at managing and preventing clinical manifestations, or a stem cell transplant from a familial donor.Developed by Fondazione Telethon
Show less
Read more
Impact Snapshot
Event Time:
ASGLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ASGLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ASGLY alerts
High impacting AGC INC UNSP/ADR news events
Weekly update
A roundup of the hottest topics
ASGLY
News
- Korea University Researchers Revive an Abandoned Depression Drug Target Using Structurally Novel NK1 Receptor Inhibitors [Yahoo! Finance]Yahoo! Finance
- Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector ProductionBusiness Wire
- Enginzyme and AGC Create Scalable Process for Key mRNA Ingredient [Yahoo! Finance]Yahoo! Finance
- Advanced Ceramics Market Size is Expected to Reach USD 175.80 Billion by 2033 Owing to the Rising Demand for High-Performance Materials Across Industries Globally | SNS Insider [Yahoo! Finance]Yahoo! Finance
- Uncovering Asia's Hidden Small Cap Gems with Solid Foundations [Yahoo! Finance]Yahoo! Finance